Medicine

Integrating liver endpoints in clinical trials of heart as well as renal condition

.Nature Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint requires incorporation of individuals with MASLD and dimension of liver outcomes in cardio-- kidney-- metabolic tests, when records recommend mechanistically tenable advantages and also professional security-- and also summarizes considerations for test concept and governing commendation.

Articles You Can Be Interested In